Immediate Impact

1 from Science/Nature 65 standout
Sub-graph 1 of 24

Citing Papers

Reshaping the immune microenvironment and reversing immunosenescence by natural products: Prospects for immunotherapy in gastric cancer
2025 Standout
Self-Cascaded Pyroptosis-STING Initiators for Catalytic Metalloimmunotherapy
2025 Standout
1 intermediate paper

Works of Jianwei Lu being referenced

Pembrolizumab versus paclitaxel for previously treated advanced gastric or gastroesophageal junction cancer (KEYNOTE‐063): A randomized, open‐label, phase 3 trial in Asian patients
2021
Long non-coding RNA XIST promotes the development of esophageal cancer by sponging miR-494 to regulate CDK6 expression
2018

Author Peers

Author Last Decade Papers Cites
Jianwei Lu 333 547 200 425 59 994
Cheng Huang 343 506 268 320 80 1.1k
Bin Huang 234 658 201 356 59 1.2k
Yunfeng Shan 290 607 190 381 66 1.1k
Hideaki Kinugasa 521 438 265 463 63 1.2k
Wei Guo 288 393 152 268 68 949
Xueshuai Wan 344 411 260 356 48 1.0k
Yongfu Xiong 250 504 204 308 55 967
Yan Zhu 389 506 238 341 68 1.2k
Xiaoyan Bai 283 591 308 396 53 1.1k
Meenu Jain 241 606 144 501 60 1.2k

All Works

Loading papers...

Rankless by CCL
2026